Eficacia diagnóstica de la biopsia dirigida por TAC en la detección de masas pulmonares. Revisión Sistemática

Abstract

Abstract: Percutaneous lung biopsy guided by computed axial tomography (CAT) is a useful technique for the histological and cytological study of focal or diffuse lesions. This procedure aims to obtain a histopathological diagnosis, for which different types of needles can be used, fine needle aspiration biopsy (FNAB) or core needle biopsy (CNB), supported by computed axial tomography (CAT). Fine needle aspiration biopsy (FNAB) shows an accuracy of 90 to 96.8% in lesions larger than 3 cm in diameter; in lesions of smaller diameter, the diagnosis is 60 to 80%; in benign lesions, it is 70%; and in malignant lesions 90.6%. Methodology: The PRISMA 2020 method will be employed, conducting literature reviews in scientific databases, scientific articles, and systematic reviews, using DeCs and MeSH keywords and Boolean operators in the following databases: PubMed, Scopus, Latindex, National Library of Medicine, Cochrane Library, Cinhal, UpToDate, SciELO, and repositories of different Universities at national and international level. Results: The results were taken based on the application of inclusion and exclusion criteria and the analysis of retrospective studies, descriptive studies, bibliographic reviews, manuals, and clinical practice guidelines. Discussion: More information about the procedure's effectiveness will be obtained by analyzing different studies and bibliographies. Conclusions: CTA-guided percutaneous lung biopsy is a safe and reliable method with high efficacy.